What does FARMA SPRUYT do?

FARMA SPRUYT is a pharmacy in Kortenberg. Public Limited, started on 27 May 1997, 1 establishment.

What is the address of FARMA SPRUYT?

The registered office of FARMA SPRUYT is located at Annonciadenstraat 38, 3078 Kortenberg.

Is FARMA SPRUYT still active?

Yes. According to the CBE (31 October 2026) FARMA SPRUYT is active, legal situation “Normale toestand”, started on 27 May 1997.

Is FARMA SPRUYT registered on Peppol?

Yes, FARMA SPRUYT is registered on the Peppol network with ID 0208:0460739013.

What is the enterprise number of FARMA SPRUYT?

The enterprise number of FARMA SPRUYT is BE0460739013.

When was FARMA SPRUYT founded?

FARMA SPRUYT was founded on 27 May 1997.

Who are the directors of FARMA SPRUYT?

According to the 2025 annual accounts, the directors of FARMA SPRUYT are: Marie Dusselier, Filip Goeminne.

Is FARMA SPRUYT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 May 1997; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did FARMA SPRUYT make in 2025?

FARMA SPRUYT recorded a loss after taxes of € 223 in financial year 2025.

What is the revenue of FARMA SPRUYT?

As a small company, FARMA SPRUYT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 179,667.

How much does an employee at FARMA SPRUYT earn?

The average wage cost per full-time employee at FARMA SPRUYT was € 51,900 in 2023: staff costs of € 67,487 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

FARMA SPRUYT (Public Limited) - Kortenberg - BE0460739013

Dossier FARMA SPRUYT, printed on 31 October 2026 from databakkes.be/en/0460739013/farma-spruyt. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

FARMA SPRUYT from Kortenberg, company number BE0460739013, closed financial year 2025 with a result of € -223 after tax. For that financial year FARMA SPRUYT recorded a gross margin of € 179,667 and equity of € 1 million. Compared with financial year 2024, the result moved from € 71,923 to € -223. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Healthy

€ 1 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -223

▼ still € 71,923 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,074

▲ 257% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 976,983.

People and assets in 2025

Wage cost

€ 145,405

▲ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,908

▼ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 53,548

▼ 28% vs 2024

€ 17,578 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 13,700

▲ € 13,100 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 61,960

▼ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 77,118 Gross margin 2022: € 77,118 First fiscal year in the series	€ 125,077 Gross margin 2023: € 125,077 ▲ 62% vs 2022 (€ 77,118) Favourable step	€ 304,538 Gross margin 2024: € 304,538 ▲ 143% vs 2023 (€ 125,077) Favourable step	€ 179,667 Gross margin 2025: € 179,667 ▼ 41% vs 2024 (€ 304,538) Unfavourable step	▼ 41%
Profit after taxes	€ -28,929 Profit after taxes 2022: € -28,929 First fiscal year in the series	€ 21,808 Profit after taxes 2023: € 21,808 ▲ € 50,737 vs 2022 (€ -28,929) Favourable step	€ 71,923 Profit after taxes 2024: € 71,923 ▲ 230% vs 2023 (€ 21,808) Favourable step	€ -223 Profit after taxes 2025: € -223 ▼ € 72,145 vs 2024 (€ 71,923) Unfavourable step	▼ € 72,145
Equity	€ 1,144,342 Equity 2022: € 1,144,342 First fiscal year in the series	€ 1,043,032 Equity 2023: € 1,043,032 ▼ 9% vs 2022 (€ 1,144,342) Unfavourable step	€ 1,039,180 Equity 2024: € 1,039,180 Unchanged (€ 1,043,032) Unfavourable step	€ 1,038,957 Equity 2025: € 1,038,957 Unchanged (€ 1,039,180) Unfavourable step
Total debts	€ 152,443 Total debts 2022: € 152,443 First fiscal year in the series	€ 149,907 Total debts 2023: € 149,907 ▼ 2% vs 2022 (€ 152,443) Favourable step	€ 145,025 Total debts 2024: € 145,025 ▼ 3% vs 2023 (€ 149,907) Favourable step	€ 130,458 Total debts 2025: € 130,458 ▼ 10% vs 2024 (€ 145,025) Favourable step	▼ 10%
Cash	€ 2,487 Cash 2022: € 2,487 First fiscal year in the series	€ 13,307 Cash 2023: € 13,307 ▲ € 10,820 vs 2022 (€ 2,487) Favourable step	€ 12,345 Cash 2024: € 12,345 ▼ 7% vs 2023 (€ 13,307) Unfavourable step	€ 44,074 Cash 2025: € 44,074 ▲ 257% vs 2024 (€ 12,345) Favourable step	▲ 257%
Land & buildings	€ 336,419 Land & buildings 2022: € 336,419 First fiscal year in the series	€ 323,324 Land & buildings 2023: € 323,324 ▼ 4% vs 2022 (€ 336,419) Unchanged	€ 310,380 Land & buildings 2024: € 310,380 ▼ 4% vs 2023 (€ 323,324) Unchanged	€ 295,669 Land & buildings 2025: € 295,669 ▼ 5% vs 2024 (€ 310,380) Unchanged	▼ 5%
Retained profit	€ 1,082,368 Retained profit 2022: € 1,082,368 First fiscal year in the series	€ 981,059 Retained profit 2023: € 981,059 ▼ 9% vs 2022 (€ 1,082,368) Unfavourable step	€ 977,206 Retained profit 2024: € 977,206 Unchanged (€ 981,059) Unfavourable step	€ 976,983 Retained profit 2025: € 976,983 Unchanged (€ 977,206) Unfavourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 123,117 Dividend 2023: € 123,117 Unchanged (€ 0) Unchanged	€ 75,775 Dividend 2024: € 75,775 ▼ 38% vs 2023 (€ 123,117) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 75,775) Unchanged	▼ 100%
Bank debt	€ 119,310 Bank debt 2022: € 119,310 First fiscal year in the series	€ 91,234 Bank debt 2023: € 91,234 ▼ 24% vs 2022 (€ 119,310) Favourable step	€ 74,617 Bank debt 2024: € 74,617 ▼ 18% vs 2023 (€ 91,234) Favourable step	€ 53,548 Bank debt 2025: € 53,548 ▼ 28% vs 2024 (€ 74,617) Favourable step	▼ 28%
Balance sheet total	€ 1,374,309 Balance sheet total 2022: € 1,374,309 First fiscal year in the series	€ 1,266,290 Balance sheet total 2023: € 1,266,290 ▼ 8% vs 2022 (€ 1,374,309) Unchanged	€ 1,253,381 Balance sheet total 2024: € 1,253,381 ▼ 1% vs 2023 (€ 1,266,290) Unchanged	€ 1,234,417 Balance sheet total 2025: € 1,234,417 ▼ 2% vs 2024 (€ 1,253,381) Unchanged	▼ 2%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1.3 Employees (FTE) 2023: 1.3 ▲ 0.3 vs 2022 (1) Unchanged	-	-

Key figures of FARMA SPRUYT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FARMA SPRUYT?

What happened at FARMA SPRUYT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: loss of € 223 (▼ € 72,145 vs 2024). Source: NBB ↗
2022 Marie Dusselier became a director. NBB
2022 Filip Goeminne became a director. NBB
Mar 19, 1998 New establishment in Kortenberg. KBO
May 27, 1997 Start of the company according to the CBE. KBO

In short

From € 28,929 loss in 2022 to € 223 loss in 2025.

Paid € 75,210 in corporate taxes since 2022.

Best year ever: 2024, with € 71,923 profit.

On average € 96,200 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Marie Dusselier

Filip Goeminne

FARMA SPRUYT

Behind FARMA SPRUYT are Marie Dusselier and Filip Goeminne. The shares are held by Marie Dusselier and Filip Goeminne.

Directors

According to the 2025 annual accounts

Marie Dusselier

Director

Is a shareholder

Also active at: APOTHEEK SPRUYT ERPS-KWERPS

since 2022

Filip Goeminne

Director

Is a shareholder

Also active at: APOTHEEK SPRUYT ERPS-KWERPS, APOTHEEK SPRUYT EVERBERG

since 2022

Shareholders

Marie Dusselier · director

Filip Goeminne · director

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Annonciadenstraat 38

3078 Kortenberg

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK SPRUYT EVERBERG same network

€ 180,026 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0460.739.013

VAT number

BE 0460.739.013

Registered office

Annonciadenstraat 38, 3078 Kortenberg

Names & denominations

FARMA SPRUYT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 May 1997

Peppol

Active · Active since 15 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

FARMA SPRUYT

Financials

What happened to FARMA SPRUYT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions